Cognitive improvement during Tolcapone
treatment in Parkinson's disease
Gasparini M, Fabrizio E, Bonifati V, Meco G.
Department of Neurosciences,
University La Sapienza, Rome, Italy.
J Neural Transm. 1997;104(8-9):887-94
ABSTRACTThe aim of this study was to evaluate the effects of Tolcapone, a reversible, selective inhibitor of catechol-O-methyltransferase, on the cognitive function of eight patients with advanced Parkinson's disease. They underwent neuropsychological and motor assessment at baseline and were re-evaluated after 6 months. During this period, they received Tolcapone three times daily, while the L-dopa dosage was progressively reduced. Significant improvements were observed in the attentional task, auditory verbal short-term memory, visuo-spatial recall, constructional praxia and motor symptoms. These data suggest that treatment with Tolcapone, in combination with L-dopa therapy, may determine a significant improvement in cognitive resources of patients with advanced Parkinson's disease.Tolcapone
New brain cells
The memory switch?
Growing new brain cells
Piracetam and working memory
Refsand further reading
The Abolitionist Project
The Hedonistic Imperative
The Reproductive Revolution
Critique of Huxley's Brave New World
The Good Drug Guide
The Responsible Parent's Guide
To Healthy Mood Boosters For All The Family